Literature DB >> 21771024

Factors influencing reproducibility of tumour regression grading after high-dose chemoradiation of locally advanced rectal cancer.

Jan Lindebjerg1, Niels Hansborg, John Ploen, Soren Rafaelsen, Jens Christian Riis Jorgensen, Anders Jakobsen.   

Abstract

AIMS: High-dose chemoradiation is now considered the standard treatment of locally advanced rectal cancer. To provide feedback on the effect of this treatment, several regression grading systems have been proposed. For a grading system to be useful it has to be reproducible. The aim of this study was to test the reproducibility of a five-point grading system, proposed originally by Mandard, and to describe the sources of disagreement. METHODS AND
RESULTS: Tumour regression was assessed independently by two observers on 100 consecutive chemoradiated rectal cancer specimens. The grading system was extremely reproducible, with weighted and unweighted kappa values of 0.89 and 0.82, respectively. The most frequent source of disagreement was assessment of the relative amount of fibrosis. Displacement of epithelium was a minor source of disagreement.
CONCLUSIONS: The five-point grading system of Mandard is extremely reproducible.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Year:  2011        PMID: 21771024     DOI: 10.1111/j.1365-2559.2011.03888.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy.

Authors:  Reetesh K Pai; Rish K Pai
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy.

Authors:  Ane L Appelt; John Pløen; Ivan R Vogelius; Søren M Bentzen; Anders Jakobsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-03       Impact factor: 7.038

3.  Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study.

Authors:  Friedrich Prall; Oliver Schmitt; Leif Schiffmann
Journal:  World J Surg Oncol       Date:  2015-04-21       Impact factor: 2.754

4.  Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.

Authors:  Francesco Sclafani; Gina Brown; David Cunningham; Andrew Wotherspoon; Larissa Sena Teixeira Mendes; Svetlana Balyasnikova; Jessica Evans; Clare Peckitt; Ruwaida Begum; Diana Tait; Josep Tabernero; Bengt Glimelius; Susana Roselló; Janet Thomas; Jacqui Oates; Ian Chau
Journal:  Br J Cancer       Date:  2017-09-21       Impact factor: 7.640

5.  MRI tumour regression grade in locally recurrent rectal cancer.

Authors:  Eva L K Voogt; Stefi Nordkamp; Desley M G I van Zoggel; Alette W Daniëls-Gooszen; Grard A P Nieuwenhuijzen; Johanne G Bloemen; Geert-Jan Creemers; Jeltsje S Cnossen; Gesina van Lijnschoten; Jacobus W A Burger; Harm J T Rutten; Joost Nederend
Journal:  BJS Open       Date:  2022-05-02

Review 6.  Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment.

Authors:  Svenja Thies; Rupert Langer
Journal:  Front Oncol       Date:  2013-10-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.